LiGHT 2026

Pharmacy Integration After Hospital Mergers

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Trust Through Candor: Sanofi’s Dr. Mary...

Questions on clinical safety and communication perspective Your review...

Meningococcal Disease Is Not Just a...

1. Your paper in Infectious Diseases and Therapy describes...

LiGHT 26 Interview with Penny Moyses,...

1. Key trends in architectural/specification lighting and their influence...

1. Hospital M&A is rebounding after a 15-year low. Why should pharmacy be on the executive agenda from day one after a deal closes?

It is extremely difficult to realize the clinical, operational and financial outcomes of a deal if Pharmacy is not on the executive agenda because Pharmacy manages one of the most expensive and tightly regulated inventories in the system. With hospitals and health systems having announced 22 mergers and acquisitions (M&A) in the first quarter of 2026 and 18 in the second, each deal brings more hospitals and pharmacies, each with its own way of procuring, tracking and managing medications, into one organization.

These decisions affect how reliably clinicians can get the medications patients need and how much the system spends to keep them available. Bringing pharmacy leaders into deal planning early allows them to identify risks to medication access and show finance leaders where changes to purchasing or inventory management could optimize costs.

2. What are the most common pharmacy challenges health systems face when combining hospitals with different workflows, inventory processes and technologies?

When organizations come together, leaders have to reconcile medication inventories, purchasing arrangements, pharmacy workflows and systems across sites of care and locations. Every health system holds its own version of the truth about medications, and the gaps between its systems are where doses go missing, diversion hides and drug spend climbs. If one hospital tracks stock differently from another, pharmacy leaders may have to reconcile records by hand before they can tell what is available across the system.

Imagine overseeing 40 dispensing cabinets across six hospitals without a shared inventory view. A pharmacy technician may have to check multiple systems or call another site to locate a dose.

Staffing makes this harder. In 2025, 92% of hospitals reported shortages of sterile compounding technicians. When staffing is tight, teams have less capacity and flexibility to take on integration work alongside their day-to-day responsibilities.

3. Many organizations still treat pharmacy as a cost center. Why does that approach become a limitation as health systems grow?

Health systems often manage drug spend, supply and workforce as separate budget lines with separate owners. Pharmacy’s financial impact is real but often invisible to the C-suite, so it rarely makes it into enterprise planning. Pharmacy influences the quality of clinical care and operational outcomes and can really be an enabler of greater financial outcomes. Industry experts put at least 25% of health system net revenue coming from pharmacy, while the median hospital operating margin was 2.5% in the first half of 2026. At a 2.5% median operating margin, pharmacy savings can matter to the overall budget.

As health systems expand into ambulatory clinics, infusion centers, specialty pharmacy and home-based care, pharmacy leaders can help plan how each site will stock medications and how patients will access them. Ultimately, Pharmacy getting a seat at the table and engaged as a strategic partner has the potential to unlock better overall outcomes for the health system.

4. Where do health systems typically find hidden operational and financial value once medication data is connected across all their sites?

One of the first places to look is inventory that is sitting unused at one hospital while another site places a new order. A systemwide view of stock and demand can help teams coordinate purchases or, where permitted, redistribute medications before they expire. The potential to manage medications as an enterprise discipline and approach can unlock hidden operational, clinical and financial value.

Staff time is another source of value. If technicians spend less time calling other sites to locate a medication, pharmacists and technicians can spend more time on clinical and patient care activities within their roles. Track how much time staff spend locating medications or managing shortages to see whether the changes are helping.

5. How does limited visibility across sites lead to issues such as duplicate purchasing, stockouts or unnoticed diversion, and how can leaders address these gaps early?

Without a shared enterprise view of stock and demand, one hospital may place an order while another has the same medication sitting unused. Separate dispensing records can also make it harder to identify patterns that warrant a diversion review.

A pharmacy director responsible for six hospitals needs timely access to stock levels, expiring product and unusual dispensing patterns in one place, before someone calls to say a dose is missing. That gives the team a chance to investigate unusual activity or address a supply gap before it disrupts care.

Leaders can start by mapping medication inventory and demand across sites and identifying where the biggest gaps are. Standardized workflows give earlier signals on diversion and waste. Assigning an executive sponsor and an operational owner, with time and resources for training and ongoing review, keeps that work accountable.

6. With hospital drug expenses rising sharply, which decisions in the first months of integration have the biggest long-term impact on medication costs?

Drug expenses rose 9% year over year in April 2026, compared with 4% for labor. Drug spending is growing more than twice as fast as staffing costs, which usually get the most budget attention, yet it is often still managed one department and one site at a time. When each hospital or department makes buying, storage and usage decisions separately, that spending is harder to control.

In the first few months, it’s important to understand ordering, inventory and dispensing patterns as well as the supporting culture, processes and systems before committing to a systemwide technology change. Decide on which purchasing decisions can be made at the enterprise or site level and which changes need a pilot. It’s important to take a step back and align the organization behind a clear set of strategic goals, a roadmap on how to get there and key metrics of success. This will help prioritize the right moves in the right order, aligned with the strategic goals of the enterprise.

7. Why should drug shortages, costs, workforce strain and medication safety be managed together rather than as separate priorities?

A disruptive event within a health system quickly becomes an enterprise issue. For example, a single supply disruption can raise drug costs, pull staff away from other work, increase frustration and force changes to how a medication is prepared or administered. Managing those effects together helps leaders see what a decision in one department will mean for another, and the patient.

A shortage shows how these pressures connect. The United States had 75 active drug shortages at the end of 2025, lasting 5.3 years on average. A shortage can pull staff away from routine work to source substitutes and update workflows. If the substitute comes in a different concentration, teams may also need to update preparation instructions and communicate the change before it reaches patients.

A practical starting point is bringing pharmacy, nursing, finance and operations together to identify handoffs that rely on manual workarounds.

8. What should leaders standardize, what should they keep local, and what should they connect when integrating pharmacy operations across a newly combined system?

These choices should be influenced by the strategic goals of the health system with regards to its medication management approach. It is important to standardize the processes that protect safety and compliance and enable enterprise visibility and action. Standardized processes and embedded clinical and data safeguards support adherence to regulatory standards, enterprise visibility and benchmarking, enabling proactive decision-making.

Keep workflows local where patient needs, services or applicable requirements differ. For example, an infusion center and an inpatient unit may need different stocking levels or replenishment schedules. It’s also important to involve frontline staff in testing those workflows.

Finally, connect the medication data. The complexity of a combined system cannot be solved by optimizing one site, one department or one workflow at a time. One connected view of the medication journey lets pharmacy see risk, cost and outcomes across every site instead of one system at a time.

9. What advice would you give health system executives entering their first 100 days of a merger or acquisition?

Deal planning starts before the deal is announced. On day 1, ensure that there is a clear strategic outcome thesis for pharmacy that can be validated over time, name an executive sponsor and a pharmacy operations lead, then ask them to identify the biggest opportunities and risks to medication management across the health system. Next, fully understand baseline for measures such as medication availability, stock-outs, expired inventory and staff time spent locating medications. By day 100, define enterprise success measures and how these will be achieved over time.

Budget time for training and workflow changes from the start. Ask frontline staff what is still taking extra work and give the pharmacy operations lead responsibility for addressing those issues post deal close.

Three principles should guide the work. Pharmacists’ clinical judgement stays central, safety comes before speed and outcomes are measured at the bedside and on the balance sheet.

Author
Author Image
Nnamdi Njoku
Omnicell
Omnicell
Company Logo

Hospital & Healthcare Management brings together the global healthcare industry — from hospital administrators and clinical directors to health technology innovators and policy leaders — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium healthcare industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global hospital and healthcare management value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Related stories

LiGHT 26 Interview with Penny Moyses, Group Event Director

1. Key trends in architectural/specification lighting and their influence...

The Future of Clinical Care: Dr. Kristen Wyrick on Ambient AI at Optum

Exclusive Insights from Leaders: Hospital & Healthcare Management (HHM...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »